Entry |
|
Name |
Disitamab vedotin (USAN/INN) |
Efficacy |
Antineoplastic |
Type |
Antibody-drug conjugate |
Target |
|
Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
EGFR family
ERBB2 (HER2, CD340)
D12989 Disitamab vedotin (USAN/INN)
Not elsewhere classified
Cellular process
Cytoskeleton
TUBB
D12989 Disitamab vedotin (USAN/INN)
|
Other DBs |
|
LinkDB |
|